J Med Microbiol NEW Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ayala, G.
Right arrow Articles by López-Carrillo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ayala, G.
Right arrow Articles by López-Carrillo, L.
Agricola
Right arrow Articles by Ayala, G.
Right arrow Articles by López-Carrillo, L.
J Med Microbiol 57 (2008), 9-14; DOI: 10.1099/jmm.0.47550-0
© 2008 Society for General Microbiology
ISSN 1473-5644

Association between Helicobacter pylori VacA antigens and gastric cancer depends on the detection method used: immunoblot versus neutralization of the vacuolating activity of VacA

Guadalupe Ayala, Julia Torres-Mena and Lizbeth López-Carrillo

National Institute of Public Health of Mexico. Av. Universidad No. 655, Col. Santa Ma. Ahuacatitlán, 62508 Cuernavaca, Morelos, Mexico

Correspondence
Lizbeth López-Carrillo
lizbeth{at}insp.mx

Received 2 August 2007
Accepted 20 September 2007

There are inconsistent findings on the association between Helicobacter pylori anti-VacA antibodies and gastric cancer (GC) risk. The lack of optimally sensitive and specific methods to detect anti-VacA antibodies may partly be responsible for this discrepancy. The aim of this study was to compare the association between GC and the presence of anti-VacA antibodies using two different detection methods. A secondary analysis of sera collected in a hospital-based case–control study in three geographical areas of Mexico was performed. Anti-VacA antibodies were determined by a neutralization assay and an immunoblot assay in serum samples of 203 histologically confirmed GC cases and 430 age- and sex-matched controls. H. pylori IgG status was determined by immunoblotting and H. pylori CagA status data was available for this study. Unconditional logistic regression models were used to estimate the association between anti-VacA antibodies and GC by histological type (diffuse and intestinal). Anti-VacA seroprevalence was higher using neutralization compared with immunoblotting: 68.5 vs 44.3 % for cases and 60.5 vs 44.2 % for controls. A significant association between anti-VacA antibodies and diffuse GC was found using neutralization [odds ratio (OR)=1.69, 95 % CI 1.08–2.66], but the association did not remain significant after adjusting for CagA status (OR 1.37, 95 % CI 0.81–2.32). No association between anti-VacA antibodies and GC was found when using immunoblotting. Thus, the association between anti-VacA antibodies and GC partly depends on the detection method used. These results do not support an independent role for VacA in GC risk in the presence of CagA seropositivity and strengthen the importance of CagA as a potential risk factor for GC.

Abbreviations: GC, gastric cancer; OR, odds ratio; SVA, supernatants with vacuolating activity.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2008 Society for General Microbiology.